IASR Vol.43 No.1 (No. 503) January 2022 Rubella and congenital rubella syndrome in Japan as at November 2021

PDFdownload（PDF：514KB）

Rubella and congenital rubella syndrome in Japan as at November 2021

Congenital rubella syndrome cases notified in 2019-2021
Rubella testing at the Tokyo Metropolitan Institute of Public Health
The period from prodromal fever onset to rash onset in laboratory-confirmed rubella cases: a cross-sectional study
A case that was rubella IgM antibody-positive but rubella HI and rubella IgG antibody-negative during pregnancy
Rubella vaccination coverage and seroprevalence in Japan, FY2020–National Epidemiological Surveillance of Vaccine–Preventable Diseases (provisional results)
Routine immunization coverage of vaccines containing rubella for the first dose and second dose (FY 2016-2020)
Current global situation and issues regarding rubella and congenital rubella syndrome
Rubella prevention campaign from the obstetrician-gynecologist’s perspective
Active epidemiological investigation of COVID-19 cases diagnosed after COVID-19 vaccination (second report)
Antibody responses in cases diagnosed as COVID-19 after vaccination
Comparative analysis of SARS-CoV-2 isolation in nasal/nasopharyngeal swabs and saliva samples from COVID-19 patients, Toyama Prefecture
A cluster of COVID-19 breakthrough infections in a long-term care facility for the elderly with 100% COVID-19 vaccination coverage
Pathogens detected in confirmed and suspected COVID-19 cases reported in the NESID Infectious Agents Surveillance System (January 2020 to January 2022)